SCHEMBL7186706

SCHEMBL7186706

COSc1ccccc1[O]

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33
CA14 Q9ULX7 1/20 0.32
POLB P06746 3/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAP2K7 O14733 1/20 0.31
GMNN O75496 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15899168 0.84 CA1 (0.38) CA4CA12CA1CA2CA7
SCHEMBL1688313 0.75 TSHR (0.43) CA4CA12CA1CA2CA7
SCHEMBL20665030 0.75 ACHE (0.41) POLBHSD17B10KDM4EALDH1A1MAPT
SCHEMBL13784392 0.75 GABRA1 (0.41) CA1CA2LMNACYP1A2CYP3A4
SCHEMBL7186712 0.73 TSHR (0.44) CA4CA12CA1CA2CA7
SCHEMBL15097501 0.73 ACHE (0.39) POLBALDH1A1RAB9ASMN1; SMN2TDP1
SCHEMBL12686351 0.73 IDO1 (0.32) CA4CA12CA1CA2CA7
SCHEMBL1713269 0.73 CA1 (0.55) CA4CA12CA1CA2CA7
SCHEMBL1983082 0.73 MAPT (0.54) POLBHSD17B10KDM4EGMNNALDH1A1
SCHEMBL7526557 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192178-A2 RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) ELI LILLY AND COMPANY (US) 2002-04-03 EP claimed
WO-2000078795-A2 RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) ELI LILLY AND COMPANY (US) 2000-12-28 WO claimed
US-11739171-B2 Method for producing α-olefin/(meth)acrylic acid ester copolymer JAPAN POLYETHYLENE CORPORATION (JP) 2023-08-29 US disclosed
CN-111971310-B Process for producing alpha-olefin/(meth) acrylate copolymer 日本聚乙烯株式会社 2023-07-18 CN disclosed
US-20210122853-A1 METHOD FOR PRODUCING alpha-OLEFIN/(METH)ACRYLIC ACID ESTER COPOLYMER JAPAN POLYETHYLENE CORPORATION (JP) 2021-04-29 US disclosed
EP-3800207-A1 METHOD FOR PRODUCING & ALPHA-OLEFIN/(METH)ACRYLIC ACID ESTER COPOLYMER Japan Polyethylene Corporation (JP) 2021-04-07 EP disclosed
CN-111971310-A Process for producing alpha-olefin/(meth) acrylate copolymer 日本聚乙烯株式会社 2020-11-20 CN disclosed
WO-2019188499-A1 METHOD FOR PRODUCING α-OLEFIN/(METH)ACRYLIC ACID ESTER COPOLYMER 日本ポリエチレン株式会社 2019-10-03 WO disclosed
US-6627714-B2 Copolymerizing ethylene and dicyclopentadiene or tricyclopentadiene, and cyclic olefin in presence of metallocene catalyst to produce copolymer MARUZEN PETROCHEMICAL CO., LTD. (JP) 2003-09-30 US disclosed
US-20020058767-A1 Method for producing an olefin type copolymer having a cyclic structure MARUZEN PETROCHEMICAL CO., LTD. (JP) 2002-05-16 US disclosed
EP-1205497-A2 Method for producing an olefin type copolymer having a cyclic structure MARUZEN PETROCHEMICAL CO., LTD. (JP) 2002-05-15 EP disclosed